phenyl acetate has been researched along with Respiratory Syncytial Virus Infections in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (38.89) | 29.6817 |
| 2010's | 9 (50.00) | 24.3611 |
| 2020's | 2 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Abbadi, BL; Antunes, KH; Basso, LA; Bizarro, CV; Cassão, G; Custovic, A; da Silva, EF; de Freitas, DN; de Souza, APD; Dornelles, M; Duarte, L; Epifanio, M; Fachi, JL; Franceschina, C; Gonçalves, JIB; Gonzalez, A; Guima, S; Jones, M; Jorge, TR; Leitão, L; Machado, P; Mansur, DS; Mayer, FQ; Mocellin, M; Oliveira, S; Polack, FP; Pral, LP; Reis, TM; Rigo, M; Rodrigues, H; Setubal, JC; Silveira, J; Sperotto, NDM; Stein, RT; Varela, APM; Vinolo, MAR | 1 |
| Green, R; Markoutsa, E; Mayilsamy, K; McGill, AR; Mohapatra, S; Mohapatra, SS; Sivakumar, K | 1 |
| Behera, I; Decroly, E; Eléouët, JF; Fung, A; Gilman, MSA; Jin, Z; Jordan, P; Liu, C; McLellan, JS; Rigaux, P; Roymans, D; Sourimant, J; Sutto-Ortiz, P; Tcherniuk, S; Ysebaert, N | 1 |
| Ajami, NJ; Antunes, KH; Bell, D; Caballero, MT; Candreva, T; da Silva, EF; de Paula, R; de Souza, APD; Dias, GBM; Dos Santos, AÁ; Fachi, JL; Kleeberger, SR; Li, J; Mackay, CR; Maito, F; Mansur, D; Marzec, J; Mayer, FQ; Polack, FP; Pral, LP; Proença-Modena, JL; Puga, R; Rodrigues, HG; Sant'Ana, MR; Schmiele, M; Silva Clerici, MTP; Stein, RT; Vargas, JE; Vieira, AT; Vinolo, MAR; Wang, X; Zárate-Bladés, CR | 1 |
| Li, CC; Zhang, WX | 1 |
| Chen, X; Liu, EM; Peng, WS; Yang, XY | 1 |
| Guo, YS; Li, J; Ma, C; Zai, J; Zhang, J; Zou, YX | 1 |
| Chen, XQ; Dong, L; Kong, X; Liao, PY; Wu, JM; Wu, SH; Yin, PL | 1 |
| Everard, ML; Giezek, H; Hartert, TV; Knorr, B; Lu, S; Mehta, A; Nelsen, L; Patel, H; Reiss, TF | 1 |
| Azimi, P; Bisgaard, H; Dass, SB; Flores-Nunez, A; Goh, A; Halkas, A; Knorr, BA; Malice, MP; Marchal, JL; Reiss, TF | 1 |
| De Bilderling, G; De Boeck, K; Govaere, E; Proesmans, M; Raes, M; Sauer, K | 1 |
| Callaway, Z; Choi, J; Fujisawa, T; Kim, CK; Kim, HB; Kim, JT; Koh, YY; Shin, BM | 1 |
| Dakhama, A; Gelfand, EW; Han, J; Jia, Y; Okamoto, M; Shiraishi, Y; Takeda, K | 1 |
| Edell, D; Khoshoo, V; Ross, G | 1 |
| Bisgaard, H | 2 |
| Simoes, EA; Szefler, SJ | 1 |
| Cortell-Aznar, I; López-Andreu, JA; Ruiz-García, V | 1 |
3 review(s) available for phenyl acetate and Respiratory Syncytial Virus Infections
| Article | Year |
|---|---|
[Leukotriene and respiratory syncytial virus].
Topics: Acetates; Asthma; Bronchiolitis, Viral; Cyclopropanes; Cysteine; Humans; Infant; Infant, Newborn; Leukotriene Antagonists; Leukotrienes; Nasopharynx; Quinolines; Respiratory Syncytial Virus Infections; Risk Factors; Sulfides | 2013 |
Systematic review of montelukast's efficacy for preventing post-bronchiolitis wheezing.
Topics: Acetates; Age Factors; Bronchiolitis, Viral; Chi-Square Distribution; Child, Preschool; Cyclopropanes; Humans; Infant; Infant, Newborn; Leukotriene Antagonists; Odds Ratio; Quinolines; Respiratory Sounds; Respiratory Syncytial Virus Infections; Risk Factors; Sulfides; Treatment Outcome | 2014 |
Effect of interventions during acute respiratory syncytial virus bronchiolitis on subsequent long term respiratory morbidity.
Topics: Acetates; Acute Disease; Adrenal Cortex Hormones; Antiviral Agents; Bronchiolitis, Viral; Cromolyn Sodium; Cyclopropanes; Humans; Infant; Infant Welfare; Infant, Newborn; Leukotriene Antagonists; Morbidity; Prospective Studies; Quinolines; Respiratory Syncytial Virus Infections; Retrospective Studies; Sulfides | 2002 |
6 trial(s) available for phenyl acetate and Respiratory Syncytial Virus Infections
| Article | Year |
|---|---|
Clinical efficacy of montelukast sodium in treating infantile wheezing.
Topics: Acetates; Anti-Asthmatic Agents; Asthma; Bronchodilator Agents; Case-Control Studies; Cyclopropanes; Female; Humans; Infant; Male; Prospective Studies; Quinolines; Respiratory Sounds; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Sulfides; Treatment Outcome | 2014 |
Characteristics of respiratory syncytial virus-induced bronchiolitis co-infection with Mycoplasma pneumoniae and add-on therapy with montelukast.
Topics: Acetates; Bronchiolitis; Coinfection; Cyclopropanes; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Infant; Leukotriene Antagonists; Male; Pneumonia, Mycoplasma; Prospective Studies; Quinolines; Respiratory Syncytial Virus Infections; Sulfides | 2016 |
Study of montelukast for the treatment of respiratory symptoms of post-respiratory syncytial virus bronchiolitis in children.
Topics: Acetates; Bronchiolitis; Child, Preschool; Cyclopropanes; Dose-Response Relationship, Drug; Double-Blind Method; Female; Follow-Up Studies; Humans; Infant; Leukotriene Antagonists; Male; Pilot Projects; Quinolines; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Retrospective Studies; Severity of Illness Index; Sulfides; Treatment Outcome | 2008 |
Montelukast does not prevent reactive airway disease in young children hospitalized for RSV bronchiolitis.
Topics: Acetates; Bronchiolitis, Viral; Bronchodilator Agents; Chi-Square Distribution; Cough; Cyclopropanes; Double-Blind Method; Follow-Up Studies; Hospitalization; Humans; Infant; Prospective Studies; Quinolines; Respiratory Hypersensitivity; Respiratory Sounds; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Statistics, Nonparametric; Sulfides; Treatment Outcome | 2009 |
A randomized intervention of montelukast for post-bronchiolitis: effect on eosinophil degranulation.
Topics: Acetates; Acute Disease; Bronchiolitis, Viral; Cell Degranulation; Cyclopropanes; Double-Blind Method; Eosinophil-Derived Neurotoxin; Eosinophils; Humans; Infant; Quinolines; Recurrence; Respiratory Sounds; Respiratory Syncytial Virus Infections; Sulfides | 2010 |
A randomized trial of montelukast in respiratory syncytial virus postbronchiolitis.
Topics: Acetates; Bronchiolitis, Viral; Cyclopropanes; Double-Blind Method; Female; Humans; Infant; Leukotriene Antagonists; Male; Quinolines; Respiratory Syncytial Virus Infections; Sulfides | 2003 |
9 other study(ies) available for phenyl acetate and Respiratory Syncytial Virus Infections
| Article | Year |
|---|---|
Short-chain fatty acid acetate triggers antiviral response mediated by RIG-I in cells from infants with respiratory syncytial virus bronchiolitis.
Topics: Acetates; Animals; Antiviral Agents; Bronchiolitis; COVID-19; Fatty Acids, Volatile; Humans; Infant; Lung; Mice; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; SARS-CoV-2 | 2022 |
Acetate-encapsulated Linolenic Acid Liposomes Reduce SARS-CoV-2 and RSV Infection.
Topics: Acetates; alpha-Linolenic Acid; Animals; Antiviral Agents; COVID-19; Liposomes; Mice; Molecular Docking Simulation; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; SARS-CoV-2 | 2023 |
Structure of the Respiratory Syncytial Virus Polymerase Complex.
Topics: Acetates; Animals; Antiviral Agents; Catalytic Domain; Cryoelectron Microscopy; Deoxycytidine; Hydrogen Bonding; Hydrophobic and Hydrophilic Interactions; Phosphoproteins; Protein Conformation, alpha-Helical; Protein Interaction Domains and Motifs; Quinolines; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus Vaccines; Respiratory Syncytial Virus, Human; RNA-Dependent RNA Polymerase; Sf9 Cells; Spodoptera; Viral Proteins; Virus Replication | 2019 |
Microbiota-derived acetate protects against respiratory syncytial virus infection through a GPR43-type 1 interferon response.
Topics: A549 Cells; Acetates; Animals; Cell Line; Chlorocebus aethiops; Humans; Interferon Type I; Lung; Mice, Inbred C57BL; Mice, Knockout; Microbiota; Polymorphism, Single Nucleotide; Protective Agents; Receptor, Interferon alpha-beta; Receptors, G-Protein-Coupled; Respiratory Syncytial Virus Infections; Vero Cells; Viral Load | 2019 |
Predictors of asthma following severe respiratory syncytial virus (RSV) bronchiolitis in early childhood.
Topics: Acetates; Animals; Anti-Asthmatic Agents; Asthma; Bronchiolitis, Viral; Child; Child, Preschool; Cyclopropanes; Dander; Dogs; Europe; Female; Humans; Hypersensitivity; Hypersensitivity, Immediate; Infant; Interleukin-16; Interleukin-18; Interleukin-5; Longitudinal Studies; Male; Medical History Taking; Prevalence; Prospective Studies; Quinolines; Respiratory Rate; Respiratory Sounds; Respiratory Syncytial Virus Infections; Rhinitis, Allergic; Risk Factors; Severity of Illness Index; Sex Factors; Sulfides | 2016 |
Montelukast during primary infection prevents airway hyperresponsiveness and inflammation after reinfection with respiratory syncytial virus.
Topics: Acetates; Animals; Animals, Newborn; Anti-Asthmatic Agents; Bronchiolitis, Viral; Bronchoalveolar Lavage Fluid; Cyclopropanes; Cysteine; Disease Models, Animal; Inflammation; Interferon-gamma; Leukotriene Antagonists; Leukotrienes; Mice; Mice, Inbred BALB C; Quinolines; Recurrence; Respiratory Hypersensitivity; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses; Sulfides | 2010 |
Montelukast for respiratory syncytial virus bronchiolitis: significant effect or provocative findings?
Topics: Acetates; Bronchiolitis, Viral; Cyclopropanes; Humans; Leukotriene Antagonists; Quinolines; Respiratory Syncytial Virus Infections; Sulfides | 2003 |
Montelukast in RSV-bronchiolitis.
Topics: Acetates; Bronchiolitis, Viral; Child, Preschool; Cyclopropanes; Humans; Quinolines; Respiratory Syncytial Virus Infections; Sulfides | 2004 |
Montelukast in respiratory syncytial virus postbronchiolitis.
Topics: Acetates; Bronchiolitis, Viral; Cyclopropanes; Humans; Leukotriene Antagonists; Quinolines; Respiratory Syncytial Virus Infections; Sulfides | 2004 |